miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-18
DOI
10.1038/s41420-020-00387-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent progress in treating advanced prostate cancer
- (2020) Theodore Gourdin CURRENT OPINION IN ONCOLOGY
- microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation
- (2020) Maureen Labbé et al. Molecular Cancer
- MicroRNA Analysis of ATM-Deficient Cells Indicate PTEN and CCDN1 as Potential Biomarkers of Radiation Response
- (2020) Jane Bryant et al. RADIATION RESEARCH
- miRNA in prostate cancer: challenges toward translation
- (2020) Irena Abramovic et al. Epigenomics
- MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
- (2020) Chang Bao et al. Cell Death & Disease
- miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
- (2019) Rihan El Bezawy et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of miRNAs as biomarkers in prostate cancer
- (2019) J.M. Cozar et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- Landscape of Noncoding RNA in Prostate Cancer
- (2019) Junjie T. Hua et al. TRENDS IN GENETICS
- Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3
- (2019) Yuanyuan Che et al. Molecular Therapy-Nucleic Acids
- MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway
- (2018) Dawei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Androgen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer
- (2018) Xiaozhen Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Revisiting the role of Wnt/β-catenin signaling in prostate cancer
- (2018) Jeffrey A. Schneider et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Deregulation of E-cadherin, β-catenin, APC and Caveolin-1 expression occurs in canine prostate cancer and metastatic processes
- (2018) Priscila E. Kobayashi et al. RESEARCH IN VETERINARY SCIENCE
- MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells
- (2018) Robert K. Nam et al. Oncotarget
- Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1
- (2018) Bo Long et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- microRNA‐16‐5p enhances radiosensitivity through modulating Cyclin D1/E1–pRb–E2F1 pathway in prostate cancer cells
- (2018) Fang Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis
- (2017) Omar Fahmy et al. UROLOGIA INTERNATIONALIS
- MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
- (2017) Han Guan et al. Oncotarget
- Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
- (2017) Jasleen Saini et al. CURRENT DRUG TARGETS
- MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer
- (2016) You-Jin Lu et al. TUMOR BIOLOGY
- Aldehyde Dehydrogenase Is Regulated by -Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
- (2015) M. Cojoc et al. CANCER RESEARCH
- Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer
- (2014) Thomas Cordonnier et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling
- (2014) Byoung-San Moon et al. JNCI-Journal of the National Cancer Institute
- Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
- (2013) M. Shiota et al. CANCER RESEARCH
- Inhibition of Hsp27 Radiosensitizes Head-and-Neck Cancer by Modulating Deoxyribonucleic Acid Repair
- (2013) David M. Guttmann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiosensitization in prostate cancer: mechanisms and targets
- (2013) Diego A Palacios et al. BMC Urology
- Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas
- (2011) Ramamurthi Vidya Priyadarsini et al. ORAL ONCOLOGY
- Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells
- (2010) Y Gan et al. ONCOGENE
- MicroRNAs: new players in the DNA damage response
- (2010) H. Hu et al. Journal of Molecular Cell Biology
- P-Cadherin and β-catenin are useful prognostic markers in breast cancer patients; β-catenin interacts with heat shock protein Hsp27
- (2008) Mariel A. Fanelli et al. CELL STRESS & CHAPERONES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started